Evidence map›Paper›PMID 23180683›Full record

ReviewSmall (Weinheim an der Bergstrasse, Germany)2013

NLRP3 inflammasome activation induced by engineered nanomaterials.

Bingbing Sun, Xiang Wang, Zhaoxia Ji, Ruibin Li, Tian Xia

Abstract readReview
In one paragraph

Review in Small (Weinheim an der Bergstrasse, Germany), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Subchronic Inhalation of TiOJournal of applied toxicology : JAT · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Current research trends of nanomedicines.Acta pharmaceutica Sinica. B · 2023
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bingbing SunDivision of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA 90095, USA.
Xiang Wang
Zhaoxia Ji
Ruibin Li
Tian Xia

Funding

Scientific Core: Acquisition, Synthesis, and Characterization of NanomaterialsU19ES019528 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NEL, ANDRE ELIAS · 2010 to 2014
$5.5M
Predictive Toxicological Paradigm for Chronic Nanoparticle Injury in the LungR01ES016746 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NEL, ANDRE ELIAS · 2008 to 2017
$3.4M
Nanovalve Platform: Targeted, Controlled, Release of Anticancer DrugsR01CA133697 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NEL, ANDRE ELIAS, STODDART, JAMES FRASER · 2010 to 2014
$2.1M
Predictive Toxicological Paradigms to Establish Inhalation Toxicology ModelsRC2ES018766 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NEL, ANDRE ELIAS · 2009 to 2010
$1.1M
NCI NIH HHS R01 CA133697NIEHS NIH HHS R01 ES016746NIEHS NIH HHS RC2 ES018766NIEHS NIH HHS U19 ES019528
6 · The paper itself

Abstract

Engineered nanomaterials (ENMs) continue to attract significant attention because they have novel physicochemical properties that can improve the functions of products that will benefit human lives. However, the physicochemical properties that make ENMs attractive could interact with biological systems and induce cascades of events that cause toxicological effects. Recently, there have been more studies suggesting inflammasome activation may play an important role in ENM-induced biological responses. Inflammasomes are a family of multiprotein complexes that are increasingly recognized as major mediators of the host immune system. Among these, NLRP3 inflammasome is the most studied that could directly interact with ENMs to generate inflammatory responses. In this review, the ENM physicochemical properties are linked to NLRP3 inflammasome activation. An understanding of the mechanisms of ENM-NLRP3 inflammasome interactions will provide us with strategies for safer nanomaterial design and therapy.

Indexed as

NanostructuresCarrier ProteinsCathepsin BHumansInflammasomesIon TransportLysosomesNLR Family, Pyrin Domain-Containing 3 ProteinPotassiumReactive Oxygen SpeciesCarrier ProteinsCathepsin BInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanPotassiumReactive Oxygen Species

Identifiers

PMID23180683
PMCPMC4056676

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.